← Back to all trials
Completed
NCT06715345
Efficacy and Safety of Novosis Putty for Degenerative Lumbar Disease
Conditions: Degenerative Lumbar Diseases
Sex: All
Ages: 22 Years – 80 Years
Healthy volunteers: No
Phase: NA
Enrollment: 48
Sponsor: CGBio Inc.
Location: The Catholic University of Korea, Eunpyeong St. Mary's Hospital Seoul
Summary
This clinical study aims to evaluate the efficacy and safety of NOVOSIS PUTTY for bone fusion in patients requiring posterior instrumentation and transforaminal lumbar interbody fusion (TLIF) due to degenerative lumbar disease.
Eligibility Criteria
Inclusion Criteria:
* Adult aged ≥ 22 to ≤ 80 years
* Subjects whose skeletal maturation are confirmed by showing the result of Risser stage 5 in Risser classification, the Plain Radiography
* Subjects diagnosed with disc degeneration in the single level (L2-S1) lumbar spine along with spondylolisthesis of Meyerding grade 1 (degree of translocation: 0- \
Source: ClinicalTrials.gov (NCT06715345). StuddyBuddy aggregates publicly available trial information.